Main Menu

Recent posts

#91
NZX / Re: FPH - Fisher Paykel Health...
Last post by Left Field - Jul 07, 2026, 11:45 AM
Crikey, knocking on the door of $41 today.

Apparently "rotation" is the trend these days..... seems people are "rotating" out of comparatively risky SAAS and AI stocks to safer companies (like FPH.)

Whatever it is driving FPH's SP upwards, long may it last.
#92
NZX / Re: KMD Kathmandu Brands
Last post by lorraina - Jul 07, 2026, 09:55 AM
A friend of mine held Metcash shares .
Luckily he sold them when Ian Morrice joined them.
I would be selling KMD shares if I owned them...lol

"Those who cannot remember the past are condemned to repeat it."
#93
NZX / Re: KMD Kathmandu Brands
Last post by entrep - Jul 07, 2026, 09:20 AM
The jokes write themselves 🤣 🤣 🤣

I hear they have also been approaching Spark directors

Quote from: Crackity on Jul 07, 2026, 09:02 AMKMD Brands Limited appoints global retail and transformation leader as non-executive director
 
 KMD Brands Limited (ASX/NZX: "KMD", "KMD Brands" or the "Group") today announces the appointment of Ian Morrice as an independent non-executive director to the Board, effective 20 August 2026, following the Board renewal process announced in May 2026.
 
 Mr Morrice brings more than 30 years of senior leadership, business transformation and strategic advisory experience across the retail, consumer and wholesale sectors in New Zealand, Australia, the United States and United Kingdom.
 
 He is best known for his leadership of large publicly listed businesses, including as Group Chief Executive Officer of Metcash Limited and Chief Executive Officer of The Warehouse Group, where he led business transformation initiatives, strengthened organisational capability and delivered shareholder value.


I'd be taking WHS off my resume if I'd been CEO.....

#94
NZX / Re: KMD Kathmandu Brands
Last post by Crackity - Jul 07, 2026, 09:02 AM
KMD Brands Limited appoints global retail and transformation leader as non-executive director
 
 KMD Brands Limited (ASX/NZX: "KMD", "KMD Brands" or the "Group") today announces the appointment of Ian Morrice as an independent non-executive director to the Board, effective 20 August 2026, following the Board renewal process announced in May 2026.
 
 Mr Morrice brings more than 30 years of senior leadership, business transformation and strategic advisory experience across the retail, consumer and wholesale sectors in New Zealand, Australia, the United States and United Kingdom.
 
 He is best known for his leadership of large publicly listed businesses, including as Group Chief Executive Officer of Metcash Limited and Chief Executive Officer of The Warehouse Group, where he led business transformation initiatives, strengthened organisational capability and delivered shareholder value.


I'd be taking WHS off my resume if I'd been CEO.....
#95
NZX / Re: ATM-A2 MILK
Last post by Minimoke - Jul 07, 2026, 08:56 AM
The value of having a diversified product range shining through. Despite supply chain issues A2 on target this financial year
- Revenue of approximately $1.97 billion, up over 12% on FY25 (April Guidance was low to mid double-digit growth)
- EBITDA % margin to be at the high end of the April Guidance of 14.0% to 14.5%
- NPAT to be slightly up on FY25 reported (April Guidance was similar to down) with Underlying NPAT expected to be up
- Cash conversion to be approximately 70% (April Guidance was 50%)



Insiders have been busy the last couple of days


"The a2 Milk Company Limited (the Company, a2MC) provides a supply chain update in relation to its China infant milk formula (IMF) business and an update on its preliminary unaudited FY26 results.

Supply chain update

On 13 April 2026, the Company provided a Trading, Supply Chain and Outlook update that noted shortfalls of China label IMF product at distributors and retailers that would materially impact in-market product availability during 4Q26. These product shortfalls were due to a number of factors, including strong demand in the preceding quarter, freight challenges, Synlait production backlog, extended product release times, and additional customs clearance requirements and testing measures.

The Company confirms that China label IMF product availability was materially impacted by these factors in 4Q26, which necessitated a large proportion of existing users to switch to alternative brands, with some users switching to a2 English label products. The product availability impact on English label IMF product was limited and largely concentrated on a2 Genesis , which was affected by planned production downtime at a2 Pokeno and a change in China importation requirements.

The contributing factors to the product availability issues have now substantially been resolved, and product flows to distributors and retailers have materially improved across China label and English label products with stock levels returning to target levels. The Company is now focused on various sales and marketing initiatives to encourage previous China label IMF users to return while accelerating new user recruitment with its retail and distribution partners.

Preliminary FY26 results

The supply chain issues materially impacted China label IMF sales in 4Q26, with FY26 sales down approximately 14% on FY25. All other a2MC product categories, including English label IMF, Other Nutritionals and Liquid Milk, have performed strongly and are significantly up on FY25.

Based on preliminary unaudited financial results (which are subject to finalisation and external audit), the Company expects to deliver FY26 results in line with, or slightly ahead of, the guidance range previously announced on 13 April 2026 (April Guidance) (expressed on a continuing operations basis):

• Revenue of approximately $1.97 billion, up over 12% on FY25 (April Guidance was low to mid double-digit growth)
• EBITDA % margin to be at the high end of the April Guidance of 14.0% to 14.5%
• NPAT to be slightly up on FY25 reported (April Guidance was similar to down) with Underlying NPAT expected to be up
• Cash conversion to be approximately 70% (April Guidance was 50%)

The Company will release its FY26 audited results and FY27 outlook commentary on 17 August 2026."
#96
NZX / Re: AFT Pharmaceuticals
Last post by Minimoke - Jul 07, 2026, 08:51 AM
Quote from: Left Field on Jul 07, 2026, 08:45 AMUseful update.... not marked Price Sensitive.......IFT sound v pleased with their R & D and product developments.

https://www.nzx.com/announcements/475724


Kudos to AFT for keeping the market updated. A2 could learn a thing or two.
#97
NZX / Re: AFT Pharmaceuticals
Last post by Left Field - Jul 07, 2026, 08:45 AM
Useful update.... not marked Price Sensitive.......IFT sound v pleased with their R & D and product developments.

https://www.nzx.com/announcements/475724

#98
NZX / Re: Oceania Healthcare strateg...
Last post by Shareguy - Jul 07, 2026, 06:56 AM
Quote from: ValueNZ on Jul 06, 2026, 08:32 PMAn update from today, busy sending out letters to shareholders.

Well done ValueNZ, following this with interest.
#99
NZX / Re: Oceania Healthcare strateg...
Last post by ValueNZ - Jul 06, 2026, 11:07 PM
Quote from: Basil on Jul 06, 2026, 10:41 PMVery impressive for the time, effort and cost involved especially (and please don't take this the wrong way) for the modest sized shareholding you have.
Not super relevant but I have some shares in street name too for various reasons which was not included in the NoM. Totals ~58,500.

Still modest yes. I will derive much more satisfaction from the massive mountains of money I'll make others if I am successful, over any gains I might make.
#100
NZX / Re: Oceania Healthcare strateg...
Last post by Basil - Jul 06, 2026, 10:41 PM
Very highly commendable effort indeed.  Very impressive for the time, effort and cost involved especially (and please don't take this the wrong way) for the modest sized shareholding you have.  You're doing larger shareholders a tremendous favour regardless of whether you are successful with your approach or not, its planted a seed of strong shareholder discontent that badly needed planting and hopefully it will germinate and reap rewards in the years ahead.  Very well done indeed ValueNZ.  I'm impressed !